Cross-reactive T-cell proliferative responses to V3 peptides corresponding to different geographical HIV-1 isolates in HIV-seropositive individuals

about

Cross-reactive T-cell proliferative responses to V3 peptides corresponding to different geographical HIV-1 isolates in HIV-seropositive individuals

Item

http://www.wikidata.org/entity/Q57499148

description

article

@en

im März 1996 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в березні 1996

@uk

name

Cross-reactive T-cell prolifer ...... n HIV-seropositive individuals

@en

Cross-reactive T-cell prolifer ...... n HIV-seropositive individuals

@nl

type

Item

label

Cross-reactive T-cell prolifer ...... n HIV-seropositive individuals

@en

Cross-reactive T-cell prolifer ...... n HIV-seropositive individuals

@nl

prefLabel

Cross-reactive T-cell prolifer ...... n HIV-seropositive individuals

@en

Cross-reactive T-cell prolifer ...... n HIV-seropositive individuals

@nl

P1476

Cross-reactive T-cell prolifer ...... n HIV-seropositive individuals

@en

P2093

P C Johnson

http://www.w3.org/2001/XMLSchema#string

R B Arlinghaus

http://www.w3.org/2001/XMLSchema#string

S J Schapiro

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical and immunologic responses to human immunodeficiency virus (HIV) type 1SF2 gp120 subunit vaccine combined with MF59 adjuvant with or without muramyl tripeptide dipalmitoyl phosphatidylethanolamine in non-HIV-infected human volunteers.

Syngeneic bone marrow transplantation and adoptive transfer of peripheral blood lymphocytes combined with zidovudine in human immunodeficiency virus (HIV) infection.

Exposure to human immunodeficiency virus (HIV) type I indicated by HIV-specific T helper cell responses before detection of infection by polymerase chain reaction and serum antibodies [corrected]

T cell function in vitro is an independent progression marker for AIDS in human immunodeficiency virus-infected asymptomatic subjects.

Viral phenotype and T cell reactivity in human immunodeficiency virus type 1-infected asymptomatic men treated with zidovudine.

Clinical, immunologic, and virologic observations related to human immunodeficiency virus (HIV) type 1 infection in a volunteer in an HIV-1 vaccine clinical trial.

Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial.

P2888

bf01540958

P304

115-124

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/BF01540958

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

KJ Sastry

Pramod N Nehete

P577

1996-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8690775

http://www.w3.org/2001/XMLSchema#string